0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 09122400 2023-08-01 2024-07-31 09122400 2024-07-31 09122400 2023-07-31 09122400 2022-08-01 2023-07-31 09122400 2023-07-31 09122400 2022-07-31 09122400 bus:LeadAgentIfApplicable 2023-08-01 2024-07-31 09122400 bus:Director1 2023-08-01 2024-07-31 09122400 bus:Director2 2023-08-01 2024-07-31 09122400 core:WithinOneYear 2024-07-31 09122400 core:WithinOneYear 2023-07-31 09122400 core:ShareCapital 2024-07-31 09122400 core:ShareCapital 2023-07-31 09122400 core:RetainedEarningsAccumulatedLosses 2024-07-31 09122400 core:RetainedEarningsAccumulatedLosses 2023-07-31 09122400 bus:Director1 2023-07-31 09122400 bus:Director1 2024-07-31 09122400 bus:Director2 2023-07-31 09122400 bus:Director2 2024-07-31 09122400 bus:Director1 2022-07-31 09122400 bus:Director1 2023-07-31 09122400 bus:Director2 2022-07-31 09122400 bus:Director2 2023-07-31 09122400 bus:Director1 2022-08-01 2023-07-31 09122400 bus:Director2 2022-08-01 2023-07-31 09122400 bus:SmallEntities 2023-08-01 2024-07-31 09122400 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 09122400 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 09122400 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 09122400 bus:AbridgedAccounts 2023-08-01 2024-07-31
COMPANY REGISTRATION NUMBER: 09122400
Transformational Outcomes Limited
Filleted Unaudited Abridged Financial Statements
31 July 2024
Transformational Outcomes Limited
Abridged Financial Statements
Year ended 31 July 2024
Contents
Pages
Report to the board of directors on the preparation of the unaudited statutory abridged financial statements
1
Abridged statement of financial position
2 to 3
Notes to the abridged financial statements
4
Transformational Outcomes Limited
Report to the Board of Directors on the Preparation of the Unaudited Statutory Abridged Financial Statements of Transformational Outcomes Limited
Year ended 31 July 2024
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the abridged financial statements of Transformational Outcomes Limited for the year ended 31 July 2024, which comprise the abridged statement of financial position and the related notes from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at www.accaglobal.com/en/member/professional-standards/rules-standards/acca-rulebook.html. Our work has been undertaken in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf.
JAY & JAY PARTNERSHIP LIMITED Chartered Certified Accountants
2 Chesterfield Buildings Westbourne Place Clifton Bristol BS8 1RU
23 April 2025
Transformational Outcomes Limited
Abridged Statement of Financial Position
31 July 2024
2024
2023
Note
£
£
Current assets
Cash at bank and in hand
99
112
Creditors: amounts falling due within one year
3,945
3,645
-------
-------
Net current liabilities
3,846
3,533
-------
-------
Total assets less current liabilities
( 3,846)
( 3,533)
-------
-------
Net liabilities
( 3,846)
( 3,533)
-------
-------
Capital and reserves
Called up share capital
10
10
Profit and loss account
( 3,856)
( 3,543)
-------
-------
Shareholders deficit
( 3,846)
( 3,533)
-------
-------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of financial position for the year ending 31 July 2024 in accordance with Section 444(2A) of the Companies Act 2006.
Transformational Outcomes Limited
Abridged Statement of Financial Position (continued)
31 July 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 19 April 2025 , and are signed on behalf of the board by:
Mr A Cheema
Director
Company registration number: 09122400
Transformational Outcomes Limited
Notes to the Abridged Financial Statements
Year ended 31 July 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 2 Chesterfield Buildings, Westbourne Place, Clifton, Bristol, BS8 1RU.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the going concern basis. This basis may not be appropriate because the company has net liabilities at 31 July 2024. The future of the company is dependent upon the continued support of the directors and the creditors. The accounts do not include any provisions for liabilities that may arise if the directors or the creditors support is withdrawn.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Directors' advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Mr A Cheema
( 1,666)
( 150)
( 1,816)
Mrs F Malik- Cheema
( 1,667)
( 150)
( 1,817)
-------
----
-------
( 3,333)
( 300)
( 3,633)
-------
----
-------
2023
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Mr A Cheema
( 1,510)
( 156)
( 1,666)
Mrs F Malik- Cheema
( 1,511)
( 156)
( 1,667)
-------
----
-------
( 3,021)
( 312)
( 3,333)
-------
----
-------
All loans are interest free and repayable on demand.